- Promote commercialization of unique technology from Japan and expansion of overseas business by combining Konica Minolta’s protein-sensitive quantitative detection technology with Ambry’s genetic diagnostic technology
- Establish genetic testing business to contribute to the promotion of precision medicine in Japan
Our Portfolio
Ambry Genetics Corporation
| Outline | Genetic testing services for breast cancer, colon cancer, and other diseases |
|---|---|
| Website | |
| Industry | Health/medicine |
| Commercialization stage | Utilization of overseas management resources |
Provided Support
| Authorized Investment | USD 400M (maximum) |
|---|---|
| Investment Structure |